Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients

被引:73
作者
Lang, Sonja [1 ]
Fairfied, Bradley [1 ]
Gao, Bei [1 ]
Duan, Yi [1 ,2 ]
Zhang, Xinlian [3 ]
Fouts, Derrick E. [4 ]
Schnabl, Bernd [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA
[3] Univ Calif San Diego, Div Biostat & Bioinformat, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[4] J Craig Venter Inst, Dept Genom Med, Rockville, MD USA
关键词
Microbiome; 16S sequencing; alcohol-related liver disease; metagenomics; GUT MICROBIOME; LIVER-DISEASE; PROFILE;
D O I
10.1080/19490976.2020.1785251
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Alcoholic hepatitis is the most severe form of alcohol-related liver disease. While the gut microbiome is known to play a role in disease development and progression, less is known about specific compositional changes of the gut bacterial microbiome associated with disease severity. Therefore, the aim of our study was to correlate gut microbiota features with disease severity in alcoholic hepatitis patients. Methods We used 16S rRNA gene sequencing on fecal samples from 74 alcoholic hepatitis patients, which were enrolled at 9 centers in Europe, the United States, and Mexico in a multi-center observational study. The relative abundance of gut bacterial taxa on genus level, as well as the microbiome diversity, was correlated to various clinical, laboratory, and histologic parameters. Results We observed a negative correlation between the model for end-stage liver disease score and Shannon diversity, independent of potentially confounding factors (P-adjust = 0.046). Alcoholic hepatitis patients with more severe disease had significantly decreased relative abundances ofAkkermansiawhile the relative abundance ofVeillonellawas increased. We observed a reduction in theBacteroidesabundance (P-adjust = 0.048) and Shannon diversity (P-adjust = 0.018) in antibiotic-treated patients and patients receiving steroids had an increase inVeillonellaabundance (P-adjust = 0.005), which was both independent of potentially confounding factors. Conclusion We observed distinct changes in the gut bacterial microbiome of alcoholic hepatitis patients with more severe disease. The gut bacterial microbiome might be an attractive target to prevent and treat this deadly disease.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity
    Bibbo, Stefano
    Abbondio, Marcello
    Sau, Rosangela
    Tanca, Alessandro
    Pira, Giovanna
    Errigo, Alessandra
    Manetti, Roberto
    Pes, Giovanni Mario
    Dore, Maria Pina
    Uzzau, Sergio
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [22] Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis
    Solis-Munoz, Pablo
    de la Flor-Robledo, Maria
    Garcia-Ruiz, Inmaculada
    Fernandez-Garcia, Carlos E.
    Gonzalez-Rodriguez, Agueda
    Shah, Naina
    Bataller, Ramon
    Heneghan, Michael
    Garcia-Monzon, Carmelo
    Solis-Herruzo, Jose A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1131 - 1142
  • [23] Prognostic factors associated with mortality in patients with severe alcoholic hepatitis
    Bargallo Garcia, Ana
    Serra Matamala, Isabel
    Marin Fernandez, Ingrid
    Masnou Ridaura, Helena
    Leal Valdivieso, Carlos
    Marcos Neira, Pilar
    Sala Llinars, Marga
    Morillas Cunill, Rosa
    Planas Vila, Ramon
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (09) : 513 - 520
  • [24] Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis
    Chang, Lei
    Qiu, Luojie
    Lei, Ningjing
    Zhou, Junying
    Guo, Ruixia
    Gao, Feng
    Dong, Shiliang
    Chen, Mengyu
    Wu, Fengling
    Qin, Bo
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [25] Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
    Qiu, Xiao-Xia
    Cheng, Sheng-Li
    Liu, Yan-Hui
    Li, Yu
    Zhang, Rui
    Li, Nan-Nan
    Li, Zheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (08) : 833 - 842
  • [26] Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Burz, Sebastian D.
    Monnoye, Magali
    Philippe, Catherine
    Farin, William
    Ratziu, Vlad
    Strozzi, Francesco
    Paillarse, Jean-Michel
    Chene, Laurent
    Blottiere, Herve M.
    Gerard, Philippe
    MICROORGANISMS, 2021, 9 (01) : 1 - 27
  • [27] Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study
    Chauhan, Ashish
    Kumar, Ramesh
    Sharma, Sanchit
    Mahanta, Mousumi
    Vayuuru, Sudheer K.
    Nayak, Baibaswata
    Kumar, Sonu
    Shalimar
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (03) : 873 - 880
  • [28] Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study
    Ashish Chauhan
    Ramesh Kumar
    Sanchit Sharma
    Mousumi Mahanta
    Sudheer K. Vayuuru
    Baibaswata Nayak
    Sonu Kumar
    Digestive Diseases and Sciences, 2021, 66 : 873 - 880
  • [29] Fecal and Sputum Microbiota and Treatment Response in Patients With Mycobacterium abscessus Pulmonary Disease
    Kim, Joong-Yub
    An, Sujin
    Kim, So Yeon
    Bae, Eunhye
    Cho, Yong-Joon
    Kwak, Nakwon
    Kim, Donghyun
    Yim, Jae-Joon
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [30] Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B
    Hodge, Alexander
    Lim, Sarah
    Goh, Evan
    Wong, Ophelia
    Marsh, Philip
    Knight, Virginia
    Sievert, William
    de Courten, Barbora
    NUTRIENTS, 2017, 9 (01):